Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05846841 · ClinicalTrials.gov registry record · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
A NA study of Smoking Cessation and Smoking, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 850
- Enrollment target
- 1
- Study location
NCT05846841: Recruiting NA study of Smoking Cessation and Smoking, sponsored by Washington University School of Medicine.
NCT05846841 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 850 participants, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (81% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05846841, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 850 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This approach may increase effectiveness and adherence for the patient, and increase the clinician's likelihood of prescribing.
Primary Outcome
This will be quantified by the proportion of enrolled patients who receive cessation medication.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Precision Treatment
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2023-09-29 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
What NCT05846841 shows while recruiting
NCT05846841 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (81% higher).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05846841 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05846841 about?
NCT05846841 is a clinical study titled "Personalized Tobacco Treatment in Primary Care (MOTIVATE)". This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobacc...
What is the current status of trial NCT05846841?
This trial is currently recruiting. It is a NA study. The enrollment target is 850 participants. The study started on 2023-09-29. Estimated completion is 2028-09-30.
What conditions does trial NCT05846841 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Physician's Role.
What interventions are being tested in trial NCT05846841?
The interventions under investigation include: Usual Care (BEHAVIORAL), Precision Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05846841?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05846841 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05846841's enrollment target sits among peer trials
850 27th of 188 higher than 162 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- NCT06526195 · 850 participants · NA
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI